"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,EP,A4,EP 2470255 A4,188-503-549-810-282,2013-02-06,2013,EP 10812549 A,2010-08-24,US 23630309 P;;US 2010/0046473 W,2009-08-24,APPARATUS FOR TRANS-CEREBRAL ELECTROPHORESIS AND METHODS OF USE THEREOF,,ALTERMAN RON L;;SHILS JAY L,ALTERMAN RON L;;SHILS JAY L,,https://lens.org/188-503-549-810-282,Search Report,no,4,0,5,5,0,A61N1/044;;A61N1/044;;A61N1/306;;A61N1/306;;A61N1/325;;A61N1/325,A61M31/00;;A61N1/04;;A61N1/30;;A61N1/32,,1,0,,,See also references of WO 2011025775A1,DISCONTINUED
2,EP,A1,EP 2470255 A1,056-235-499-135-412,2012-07-04,2012,EP 10812549 A,2010-08-24,US 23630309 P;;US 2010/0046473 W,2009-08-24,APPARATUS FOR TRANS-CEREBRAL ELECTROPHORESIS AND METHODS OF USE THEREOF,,ALTERMAN RON L;;SHILS JAY L,ALTERMAN RON L;;SHILS JAY L,,https://lens.org/056-235-499-135-412,Patent Application,yes,0,0,5,5,0,A61N1/044;;A61N1/044;;A61N1/306;;A61N1/306;;A61N1/325;;A61N1/325,A61M31/00;;A61N1/04;;A61N1/30;;A61N1/32,,0,0,,,,DISCONTINUED
3,US,A1,US 2011/0046540 A1,158-047-683-783-604,2011-02-24,2011,US 86223610 A,2010-08-24,US 86223610 A;;US 23630309 P,2009-08-24,Apparatus for Trans-Cerebral Electrophoresis and Methods of Use Thereof,"The present invention provides apparatus and methods for the delivery of therapeutic agents to target tissues by electromigration. The utilization of electric fields according to the methods of the invention aids in the distribution and targeting of therapeutic agents, in particular, where standard means of agent application in the target tissue is insufficient to achieve prophylactic or therapeutic results. In particular embodiments, the present invention utilizes a convective force in combination with the developed electric fields to further increase the flux of the therapeutic agent or to further improve distribution of the therapeutic agent within the target tissues.",ALTERMAN RON L;;SHILS JAY L,ALTERMAN RON L;;SHILS JAY L,,https://lens.org/158-047-683-783-604,Patent Application,yes,13,39,5,5,0,A61N1/044;;A61N1/044;;A61N1/306;;A61N1/306;;A61N1/325;;A61N1/325,A61N1/30,604/21;;604/501,0,0,,,,DISCONTINUED
4,CA,A1,CA 2771169 A1,058-342-221-802-424,2011-03-03,2011,CA 2771169 A,2010-08-24,US 23630309 P;;US 2010/0046473 W,2009-08-24,APPARATUS FOR TRANS-CEREBRAL ELECTROPHORESIS AND METHODS OF USE THEREOF,"The present invention provides apparatus and methods for the delivery of therapeutic agents to target tissues by electromigration. The utilization of electric fields according to the methods of the invention aids in the distribution and targeting of therapeutic agents, in particular, where standard means of agent application in the target tissue is insufficient to achieve prophylactic or therapeutic results. In particular embodiments, the present invention utilizes a convective force in combination with the developed electric fields to further increase the flux of the therapeutic agent or to further improve distribution of the therapeutic agent within the target tissues.",ALTERMAN RON L;;SHILS JAY L,ALTERMAN RON L;;SHILS JAY L,,https://lens.org/058-342-221-802-424,Patent Application,no,0,0,5,5,0,A61N1/044;;A61N1/044;;A61N1/306;;A61N1/306;;A61N1/325;;A61N1/325,A61M31/00,,0,0,,,,DISCONTINUED
5,WO,A1,WO 2011/025775 A1,084-687-536-376-630,2011-03-03,2011,US 2010/0046473 W,2010-08-24,US 23630309 P,2009-08-24,APPARATUS FOR TRANS-CEREBRAL ELECTROPHORESIS AND METHODS OF USE THEREOF,"The present invention provides apparatus and methods for the delivery of therapeutic agents to target tissues by electromigration. The utilization of electric fields according to the methods of the invention aids in the distribution and targeting of therapeutic agents, in particular, where standard means of agent application in the target tissue is insufficient to achieve prophylactic or therapeutic results. In particular embodiments, the present invention utilizes a convective force in combination with the developed electric fields to further increase the flux of the therapeutic agent or to further improve distribution of the therapeutic agent within the target tissues.",ALTERMAN RON L;;SHILS JAY L,ALTERMAN RON L;;SHILS JAY L,,https://lens.org/084-687-536-376-630,Patent Application,yes,8,0,5,5,0,A61N1/044;;A61N1/044;;A61N1/306;;A61N1/306;;A61N1/325;;A61N1/325,A61M31/00,,1,0,,,See also references of EP 2470255A4,PENDING
